Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Richard Redett III, M.D., has been named physician-in-chief for Johns Hopkins Medicine (JHM) and vice dean for clinical ...

The Lancaster County Sheriff's Office said a traffic stop on the interstate led to over $840,000 worth of prescription drugs.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Novo’s treatments for obesity and diabetes headline the government’s list of medicines that will be subject to price negotiations over the next year as part of a Biden administration effort to reduce ...

Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part D price negotiation, part of the ...

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Baltimore-based Johns Hopkins Medicine has appointed Richard Redett, MD, a pediatric plastic surgeon, as physician-in-chief. He will also serve as vice dean for clinical affairs at Johns Hopkins ...

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.